GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Isofol Medical AB (FRA:5IU) » Definitions » Price-to-Owner-Earnings

Isofol Medical AB (FRA:5IU) Price-to-Owner-Earnings : (As of May. 24, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Isofol Medical AB Price-to-Owner-Earnings?

As of today (2024-05-24), Isofol Medical AB's share price is €0.0474. Isofol Medical AB does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Isofol Medical AB's Price-to-Owner-Earnings or its related term are showing as below:


FRA:5IU's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 32.4
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-05-24), Isofol Medical AB's share price is €0.0474. Isofol Medical AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.02. Therefore, Isofol Medical AB's PE Ratio for today is At Loss.

As of today (2024-05-24), Isofol Medical AB's share price is €0.0474. Isofol Medical AB's EPS without NRI for the trailing twelve months (TTM) ended in was €-0.02. Therefore, Isofol Medical AB's PE Ratio without NRI for today is At Loss.


Isofol Medical AB Price-to-Owner-Earnings Historical Data

The historical data trend for Isofol Medical AB's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Isofol Medical AB Price-to-Owner-Earnings Chart

Isofol Medical AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only - - - - -

Isofol Medical AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Isofol Medical AB's Price-to-Owner-Earnings

For the Biotechnology subindustry, Isofol Medical AB's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Isofol Medical AB's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Isofol Medical AB's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Isofol Medical AB's Price-to-Owner-Earnings falls into.



Isofol Medical AB Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Isofol Medical AB's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.0474/-0.01
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Isofol Medical AB  (FRA:5IU) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Isofol Medical AB Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Isofol Medical AB's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Isofol Medical AB (FRA:5IU) Business Description

Traded in Other Exchanges
Address
Arvid Wallgrens Backe 20, Biotech Center, Gothenburg, SWE, SE-413 46
Isofol Medical AB is a pharmaceutical company. It is a manufacturer of folate-based therapies. The company's drug candidate Modufolin enhances the effect of the current chemotherapy treatment for patients treated for colorectal cancer. Its products are used to increase efficacy and reduce the side effects of antimetabolite cancer treatment.

Isofol Medical AB (FRA:5IU) Headlines

No Headlines